BGT — Bio-Gene Technology Share News
0.000.00%
- AU$6.10m
- AU$5.02m
- AU$0.43m
Australia's Bio-Gene Technology slips to 4-1/2-month low on discounted placement
Brief: Bio-Gene Technology Ltd Raises A$3.21 MLN Via Placement, Partially Underwritten Share Purchase Plan
Brief: Bio-Gene Technology Seeks Trading Halt
Australia's Bio‑Gene surges on Asia expansion optimism for mosquito control products
Brief: Bio-Gene Technology To Expand Flavocide And Qcide Vector Control Evaluation To Asia
Brief: Bio-Gene Technology Says Sumitomo & Nakashima To Launch Qcide Products In Japan
Australia's Bio-Gene Technology rises on deal to launch Qcide in Japan
Brief: Bio-Gene Technology Appoints Drew Speedy As CFO
Brief: Bio-Gene Technology Says Qcide Receives Organic Listing Status In USA
Brief: Bio-Gene Technology To Raise Gross Proceeds Of A$2.1 Million
Brief: Bio-Gene Technology Seeks Trading Halt
Brief: Bio-Gene Technology Gets U.S. Department Of Defense Grants Totalling A$3.0M
Australia's Bio-Gene Technology posts best day ever on $1.9 mln US grant for products
Brief: Bio-Gene Technology & Envu Collaborate To Evaluate Flavocidetm
Brief: Bio-Gene Technology Ltd Says In April, Edmond Tern Was Appointed Chief Financial Officer
Brief: Bio-Gene Technology Says Edmond Tern Appointed As CFO
Brief: Bio-Gene Technology Announces Resignation Of Joint CFO
Brief: Bio-Gene Technology Says Total Amount Raised Under Placement Has Increased To A$1.9 Mln
Brief: Bio-Gene Technology To Raise A$2.5 Million